{"content":"<li class=\"n-box-item date-title\" data-end=\"1494907199\" data-start=\"1494820800\" data-txt=\"Monday, December 23, 2019\">Monday, May 15, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3267593\" data-ts=\"1494891449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267593-windstream-rolls-out-five-strategic-nationwide-fiber-routes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream rolls out five strategic nationwide fiber routes</a></h4><ul>   <li>Windstream Holdings (<a href=\"http://seekingalpha.com/symbol/WIN\" target=\"_blank\">WIN</a> <font color='green'>+3.3%</font>) has announced opening five new <a href=\"https://seekingalpha.com/pr/16832806-windstream-wholesale-unveils-5-new-strategic-fiber-routes-nationwide-100g-network\" target=\"_blank\">strategically located fiber routes</a> on its network.</li>    <li>The new routes were made possible by the company's merger with EarthLink, and comprise: Dallas to Atlanta; Miami to Atlanta; Raleigh to Savannah; Houston to Gulfport; and Memphis to Charlotte.</li>    <li>\"Connecting several markets in the deep South, as well as along the Gulf Coast and the East Coast, these routes offer Windstream Wholesale customers even greater network efficiency and performance, along with access to our entire scalable, secure fiber solutions suite,&rdquo; says Windstream's Buddy Bayer.</li>    <li>Miami-to-Atlanta in particular serves international markets and unlocks expansion for many carriers, especially in Latin America, Bayer said.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267593\" data-linked=\"Windstream rolls out five strategic nationwide fiber routes\" data-tweet=\"$WIN $WINMQ - Windstream rolls out five strategic nationwide fiber routes https://seekingalpha.com/news/3267593-windstream-rolls-out-five-strategic-nationwide-fiber-routes?source=tweet\" data-url=\"https://seekingalpha.com/news/3267593-windstream-rolls-out-five-strategic-nationwide-fiber-routes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267591\" data-ts=\"1494891194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBVX\" target=\"_blank\">MBVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267591-mabvax-announces-4_1m-offering-to-fund-trials\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MabVax announces $4.1M offering to fund trials</a></h4><ul>   <li>MabVax Therapeutics (<a href=\"http://seekingalpha.com/symbol/MBVX\" target=\"_blank\">MBVX</a> <font color='green'>+4.7%</font>) has announced a <a href=\"https://seekingalpha.com/pr/16833664-mabvax-therapeutics-announces-4_1-million-public-offering\" target=\"_blank\">$4.1M public offering</a>.</li>    <li>The offering consists of 1,342,858 shares of common stock, and 1M shares of 0% Series G convertible preferred stock, each at an offering price of $1.75/share.</li>    <li>Shares gained into the closing bell today to end at $2.</li>    <li>The company says the preferred stock is being sold to investors who would have gone over 4.99% ownership with purchases of common stock in the offering.</li>    <li>Proceeds will be used toward funding three Phase 1 clinical trials for its antibody therapeutic, diagnostic, and radioimmunotherapy candidates, as well as follow-on programs.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267591\" data-linked=\"MabVax announces $4.1M offering to fund trials\" data-tweet=\"$MBVX $MBVXQ - MabVax announces $4.1M offering to fund trials https://seekingalpha.com/news/3267591-mabvax-announces-4_1m-offering-to-fund-trials?source=tweet\" data-url=\"https://seekingalpha.com/news/3267591-mabvax-announces-4_1m-offering-to-fund-trials\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267590\" data-ts=\"1494890857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEN\" target=\"_blank\">LEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267590-five-point-holdings-draws-320m-proceeds-in-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Five Point Holdings draws $320M proceeds in IPO</a></h4><ul>   <li>Five Point Holdings (<a href=\"http://seekingalpha.com/symbol/FPH\" target=\"_blank\">FPH</a> <font color='green'>+3.1%</font>) has <a href=\"https://seekingalpha.com/pr/16833705-five-point-holdings-llc-announces-closing-initial-public-offering-full-exercise-underwriters\" target=\"_blank\">closed its initial public offering</a> of 24.15M Class A common shares at $14/share.</li>    <li>The offering included exercise of the greenshoe option for another 3.15M shares.</li>    <li>The Coastal California real estate developer gets net proceeds of $320M, and also received $100M from a concurrent private placement to Lennar (NYSE:<a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a>).</li>    <li>Joint book-runners in the offering were Citigroup, J.P. Morgan, RBC Capital Markets and Wells Fargo Securities.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267590\" data-linked=\"Five Point Holdings draws $320M proceeds in IPO\" data-tweet=\"$LEN - Five Point Holdings draws $320M proceeds in IPO https://seekingalpha.com/news/3267590-five-point-holdings-draws-320m-proceeds-in-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/3267590-five-point-holdings-draws-320m-proceeds-in-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267582\" data-ts=\"1494887484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267582-xpresspa-acquisition-boosts-form-holdings-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XpresSpa acquisition boosts Form Holdings results</a></h4><ul>   <li>Form Holdings' (<a href=\"http://seekingalpha.com/symbol/FH\" target=\"_blank\">FH</a> <font color='green'>+4.9%</font>) <a href=\"https://seekingalpha.com/news/3267478-form-holdings-reports-q1-results\" target=\"_blank\">Q1 results</a> showed the benefit of its acquisition of ExpresSpa in December, with revenues up 615%.</li>    <li>Comparable-store sales grew 7% at XpresSpa with a 20% store-level gross profit margin.</li>    <li>Revenue by segment: Wellness (XpresSpa), $11M; Technology, $3.5M (up 172%); Intellectual Property, $0.1M.</li>    <li>Cash balance was $11.7M, with long-term debt at $6.5M.</li>    <li>It's reaffirming full-year guidance for $70M in revenue ($50M from XpresSpa, $20M from Group Mobile). It expects Group Mobile to be profitable for 2017.</li>    <li>It also said it will continue to benefit from a $13M net operating loss carryforward.</li>    <li><a href=\"http://www.globenewswire.com/news-release/2017/05/15/985088/0/en/FORM-HOLDINGS-REPORTS-FIRST-QUARTER-2017-RESULTS.html\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3267582\" data-linked=\"XpresSpa acquisition boosts Form Holdings results\" data-tweet=\"$XSPA - XpresSpa acquisition boosts Form Holdings results https://seekingalpha.com/news/3267582-xpresspa-acquisition-boosts-form-holdings-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3267582-xpresspa-acquisition-boosts-form-holdings-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267577\" data-ts=\"1494885945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRKR\" target=\"_blank\">PRKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267577-parkervisionminus-7-after-quarterly-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ParkerVision -7% after quarterly report</a></h4><ul>   <li>ParkerVision (<a href=\"http://seekingalpha.com/symbol/PRKR\" target=\"_blank\">PRKR</a> <font color='red'>-1.8%</font>) is <font color='red'>off another 7%</font> after hours, following <a href=\"https://seekingalpha.com/news/3267424-parkervision-misses-0_06\" target=\"_blank\">Q1 results</a> where it looked ahead to an awareness campaign for a new consumer Wi-Fi product, and updated on recent infringement actions against Apple, LG and Qualcomm.</li>    <li>It posted no revenue but cut its litigation expenses to result in a smaller net loss of $4.8M ($4.3M in non-GAAP terms).</li>    <li>It plans to start the awareness campaign on its new product early next month, and expects a decision in its German infringement case against Apple June 22 (with a hearing in a second case against Apple set for June 29).</li>    <li>ParkerVision had regained Nasdaq listing compliance last month.</li>    <li>The company has $6.7M in cash, equivalents, restricted cash equivalents and available-for-sale securities.</li>    <li><a href=\"https://seekingalpha.com/pr/16833395-parkervision-reports-first-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3267577\" data-linked=\"ParkerVision -7% after quarterly report\" data-tweet=\"$PRKR - ParkerVision -7% after quarterly report https://seekingalpha.com/news/3267577-parkervisionminus-7-after-quarterly-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3267577-parkervisionminus-7-after-quarterly-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267561\" data-ts=\"1494884186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267561-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/AKBA' title='Akebia Therapeutics, Inc.'>AKBA</a> <font color='green'>+14.3%</font>. <a href='https://seekingalpha.com/symbol/NC' title='NACCO Industries Inc.'>NC</a> <font color='green'>+4.6%</font>. <a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a> <font color='green'>+3.8%</font>. <a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a> <font color='green'>+2.5%</font>. <a href='https://seekingalpha.com/symbol/BURL' title='Burlington Stores, Inc'>BURL</a> <font color='green'>+2.3%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/PTX' title='Pernix Therapeutics Holdings, Inc.'>PTX</a> <font color='red'>-27.5%</font>. <a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corp.'>VOXX</a> <font color='red'>-12.6%</font>. <a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color='red'>-6.6%</font>. <a href='https://seekingalpha.com/symbol/NK' title='NantKwest'>NK</a> <font color='red'>-6.5%</font>. <a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay'>VRAY</a> <font color='red'>-4.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267561\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$AKBA $NC $ETSY - After Hours Gainers / Losers https://seekingalpha.com/news/3267561-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3267561-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267526\" data-ts=\"1494882307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFGC\" target=\"_blank\">PFGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267526-performance-food-group-announces-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Performance Food Group announces secondary offering</a></h4><ul><li>Performance Food Group (NYSE:<a href='https://seekingalpha.com/symbol/PFGC' title='Performance Food Group'>PFGC</a>) announces a secondary offering of 14M shares by selling shareholders.</li><li>The block of shares is expected to be offered out at a price of $27.70 to $27.90 per share.</li><li>PFGC<font color='red'> -0.54%</font>&nbsp;AH to $27.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267526\" data-linked=\"Performance Food Group announces secondary offering\" data-tweet=\"$PFGC - Performance Food Group announces secondary offering https://seekingalpha.com/news/3267526-performance-food-group-announces-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3267526-performance-food-group-announces-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267508\" data-ts=\"1494881651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEAR\" target=\"_blank\">TEAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267508-tearlab-hires-advisor-evaluates-strategic-alternatives-shares-down-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TearLab hires advisor as its evaluates strategic alternatives; shares down 6% after hours</a></h4><ul><li>TearLab (NASDAQ:<a href='https://seekingalpha.com/symbol/TEAR' title='TearLab Corporation'>TEAR</a>) slips&nbsp;<font color='red'>6%</font>&nbsp;after hours on light volume on the news that it has hired an investment bank to advise it on strategic alternatives.</li><li>Source: The Fly</li></ul><div class=\"tiny-share-widget\" data-id=\"3267508\" data-linked=\"TearLab hires advisor as its evaluates strategic alternatives; shares down 6% after hours\" data-tweet=\"$TEAR - TearLab hires advisor as its evaluates strategic alternatives; shares down 6% after hours https://seekingalpha.com/news/3267508-tearlab-hires-advisor-evaluates-strategic-alternatives-shares-down-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3267508-tearlab-hires-advisor-evaluates-strategic-alternatives-shares-down-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267506\" data-ts=\"1494881603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267506-hertz-pops-drops-on-mistaken-berkshire-hathaway-story\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz pops then drops on mistaken Berkshire Hathaway story</a></h4><ul><li>A newswire headline that Berkshire Hathaway had taken a stake in Hertz (NYSE:<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>) briefly sent that stock&nbsp;<font color='green'>up by nearly 10%</font>&nbsp;in after hours action.</li><li>The <a href=\"https://www.sec.gov/Archives/edgar/data/1067983/000095012317005259/xslForm13F_X01/form13fInfoTable.xml\" target=\"_blank\">just-released 13F</a> from Berkshire, however, shows no such position (at least through March 31).</li><li>HTZ remains&nbsp;<font color='green'>higher by 1%&nbsp;</font>on very active volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267506\" data-linked=\"Hertz pops then drops on mistaken Berkshire Hathaway story\" data-tweet=\"$HTZ - Hertz pops then drops on mistaken Berkshire Hathaway story https://seekingalpha.com/news/3267506-hertz-pops-drops-on-mistaken-berkshire-hathaway-story?source=tweet\" data-url=\"https://seekingalpha.com/news/3267506-hertz-pops-drops-on-mistaken-berkshire-hathaway-story\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267492\" data-ts=\"1494880786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKBA\" target=\"_blank\">AKBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267492-akebia-up-12-after-hours-on-exclusive-deal-to-supply-vadadustat-to-fresenius-dialysis-clinics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akebia up 12% after hours on exclusive deal to supply vadadustat to Fresenius dialysis clinics</a></h4><ul><li>Akebia Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKBA' title='Akebia Therapeutics, Inc.'>AKBA</a>) and Vifor Pharma Group ink an exclusive license <a href=\"https://seekingalpha.com/pr/16833412-akebia-vifor-pharma-announce-exclusive-license-agreement-provide-vadadustat-fresenius-medical\" target=\"_blank\">agreement </a>Fresenius Medical Care (NYSE:<a href='https://seekingalpha.com/symbol/FMS' title='Fresenius Medical Care AG & Co. KGAA'>FMS</a>) to supply vadadustat to its dialysis clinics upon U.S. regulatory approval.</li><li>Vifor will also make a $50M equity investment in Akebia at $14/share.</li><li>Under the terms of the deal, Vifor will exclusively distribute vadadustat to Fresenius Medica Care North America with profits to be shared with Akebia.</li><li>AKBA is up&nbsp;<font color='green'>12%</font>&nbsp;after hours on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267492\" data-linked=\"Akebia up 12% after hours on exclusive deal to supply vadadustat to Fresenius dialysis clinics\" data-tweet=\"$AKBA $AKBA $FMS - Akebia up 12% after hours on exclusive deal to supply vadadustat to Fresenius dialysis clinics https://seekingalpha.com/news/3267492-akebia-up-12-after-hours-on-exclusive-deal-to-supply-vadadustat-to-fresenius-dialysis-clinics?source=tweet\" data-url=\"https://seekingalpha.com/news/3267492-akebia-up-12-after-hours-on-exclusive-deal-to-supply-vadadustat-to-fresenius-dialysis-clinics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267491\" data-ts=\"1494880682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIPT\" target=\"_blank\">AIPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267491-skyline-medical-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skyline Medical reports Q1 results</a></h4><ul><li>Skyline Medical (SKLN): Q1 EPS of -$0.21</li><li>Revenue of $0.18M (+80.0% Y/Y)</li><li>Shares <font color='green'>+1.98%</font>.</li><li><a href='https://seekingalpha.com/pr/16833544-skyline-medical-reports-2017-first-quarter-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3267491\" data-linked=\"Skyline Medical reports Q1 results\" data-tweet=\"$AIPT $POAI - Skyline Medical reports Q1 results https://seekingalpha.com/news/3267491-skyline-medical-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3267491-skyline-medical-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267490\" data-ts=\"1494880554\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIPS\" target=\"_blank\">VIPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267490-vipshopplus-1_8-after-gains-in-customers-and-orders-drives-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vipshop +1.8% after gains in customers and orders drives beat</a></h4><ul>   <li>Vipshop Holdings (<a href=\"http://seekingalpha.com/symbol/VIPS\" target=\"_blank\">VIPS</a> <font color='red'>-0.9%</font>) has <font color='green'>gained 1.8%</font> after hours following a <a href=\"https://seekingalpha.com/news/3267436-vipshop-holdings-beats-0_01-beats-revenue\" target=\"_blank\">Q1 earnings</a> beat on top and bottom lines.</li>    <li>Revenue rose 31% to 15.95B yuan (about $2.32B) thanks to volume growth in customers and orders.</li>    <li>Gross profit increased 25% to 3.69B yuan (about $536.7M); gross margin was down slightly, to 23.2% from 24.3%.</li>    <li>Meanwhile, net income (non-GAAP) gained 28.2% to 799.4M yuan ($116.1M).</li>    <li>Active customers rose 32% to 26M; total orders rose 23% to 72.1M.</li>    <li>For Q2 it expects net revenue of 17B-17.5B yuan (Y/Y growth of 26-30%) vs. consensus expectations for 17.224B yuan.</li>    <li><a href=\"http://ir.vip.com/\" target=\"_blank\">Conference call</a> to come tomorrow at 8 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16833417-vipshop-reports-unaudited-first-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3267490\" data-linked=\"Vipshop +1.8% after gains in customers and orders drives beat\" data-tweet=\"$VIPS - Vipshop +1.8% after gains in customers and orders drives beat https://seekingalpha.com/news/3267490-vipshopplus-1_8-after-gains-in-customers-and-orders-drives-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3267490-vipshopplus-1_8-after-gains-in-customers-and-orders-drives-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267477\" data-ts=\"1494880136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDSI\" target=\"_blank\">BDSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267477-biodelivery-q1-top-line-up-883-earnings-up-273-shares-up-8-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioDelivery Q1 top line up 883%; earnings up 273%; shares up 8% after hours</a></h4><ul><li>BioDelivery Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a>) <a href=\"https://seekingalpha.com/pr/16833382-biodelivery-sciences-reports-first-quarter-2017-financial-results-provides-corporate-update\" target=\"_blank\">Q1 results</a> ($M): Revenues: 29.5 (+883.3%); Net Income: 32.4 (+273.3%); EPS: 0.58 (+261.1%); CF Ops: (9.0) (+46.1%).</li><li>BELBUCA sales: $4.6M, BUNAVAIL sales: $3.2M.</li><li>Shares are up<font color='green'> 8%</font>&nbsp;after hours on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267477\" data-linked=\"BioDelivery Q1 top line up 883%; earnings up 273%; shares up 8% after hours\" data-tweet=\"$BDSI - BioDelivery Q1 top line up 883%; earnings up 273%; shares up 8% after hours https://seekingalpha.com/news/3267477-biodelivery-q1-top-line-up-883-earnings-up-273-shares-up-8-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3267477-biodelivery-q1-top-line-up-883-earnings-up-273-shares-up-8-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267473\" data-ts=\"1494879901\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GVP\" target=\"_blank\">GVP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267473-gse-systems-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GSE Systems reports Q1 results</a></h4><ul><li>GSE Systems (NYSEMKT:<a href='https://seekingalpha.com/symbol/GVP' title='GSE Systems, Inc'>GVP</a>): Q1 EPS of $0.03</li><li>Revenue of $16.3M (+25.4% Y/Y)</li><li>Shares <font color='green'>+3.0%</font>.</li><li><a href='https://seekingalpha.com/pr/16833408-gse-systems-announces-first-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3267473\" data-linked=\"GSE Systems reports Q1 results\" data-tweet=\"$GVP - GSE Systems reports Q1 results https://seekingalpha.com/news/3267473-gse-systems-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3267473-gse-systems-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267443\" data-ts=\"1494879132\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BURG\" target=\"_blank\">BURG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267443-chanticleer-holdings-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chanticleer Holdings reports Q1 results</a></h4><ul><li>Chanticleer Holdings (HOTR): Q1 EPS of -$0.08</li><li>Revenue of $9.86M (-2.5% Y/Y)</li><li>Shares <font color='green'>+2.38%</font>.</li><li><a href='https://seekingalpha.com/pr/16833427-chanticleer-holdings-reports-operating-results-first-quarter-ended-march-31-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3267443\" data-linked=\"Chanticleer Holdings reports Q1 results\" data-tweet=\"$BURG - Chanticleer Holdings reports Q1 results https://seekingalpha.com/news/3267443-chanticleer-holdings-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3267443-chanticleer-holdings-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267423\" data-ts=\"1494878532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LQ\" target=\"_blank\">LQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267423-late-day-spike-for-la-quinta\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Late day spike for La Quinta</a></h4><ul> <li>La Quinta (<a href='https://seekingalpha.com/symbol/LQ' title='La Quinta Holdings Inc.'>LQ</a> <font color='green'>+13.5%</font>) spikes after Reuters <a href=\"http://www.reuters.com/article/us-la-quinta-m-a-exclusive-idUSKCN18B2GH\" target=\"_blank\">reports</a> the company is prepping to sell itself</li> <li>Sources indicate that the company is waiting until it files its SEC Form 10-Q before talking to interested parties.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3267423\" data-linked=\"Late day spike for La Quinta\" data-tweet=\"$LQ - Late day spike for La Quinta https://seekingalpha.com/news/3267423-late-day-spike-for-la-quinta?source=tweet\" data-url=\"https://seekingalpha.com/news/3267423-late-day-spike-for-la-quinta\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267411\" data-ts=\"1494876669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGRX\" target=\"_blank\">EGRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267411-eagle-pharma-down-14-proquest-lowers-stake-94\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eagle Pharma down 14% as ProQuest lowers stake 94%</a></h4><ul><li>Eagle Pharmaceuticals (<a href='https://seekingalpha.com/symbol/EGRX' title='Eagle Pharmaceuticals Inc.'>EGRX</a> <font color='red'>-13.7%</font>) is down &nbsp;on a 6x surge in volume on the heels of news that VC investor ProQuest has lowered its stake to 1.4% from 23.5%. Effective today, ProQuest distributed 3,584,087 common shares to partners.</li><li>Source: The Fly</li></ul><div class=\"tiny-share-widget\" data-id=\"3267411\" data-linked=\"Eagle Pharma down 14% as ProQuest lowers stake 94%\" data-tweet=\"$EGRX - Eagle Pharma down 14% as ProQuest lowers stake 94% https://seekingalpha.com/news/3267411-eagle-pharma-down-14-proquest-lowers-stake-94?source=tweet\" data-url=\"https://seekingalpha.com/news/3267411-eagle-pharma-down-14-proquest-lowers-stake-94\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267407\" data-ts=\"1494876262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPIX\" target=\"_blank\">IPIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267407-cellceutix-up-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellceutix up 17%</a></h4><ul><li>Cellceutix (CTIX <font color='green'>+16.9%</font>) is yet another small stock up on increased volume on no particular news. As far as ASCO is concerned, the company's ovarian cancer candidate <a href=\"http://www.cellceutix.com/kevetrin-1/\" target=\"_blank\">Kevetrin </a>is currently being evaluated in a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03042702\" target=\"_blank\">Phase 2 clinical trial</a> that is should wind up at year-end so an abstract on interim results may planned.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267407\" data-linked=\"Cellceutix up 17%\" data-tweet=\"$IPIX - Cellceutix up 17% https://seekingalpha.com/news/3267407-cellceutix-up-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3267407-cellceutix-up-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267398\" data-ts=\"1494874830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267398-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TRVG' title='Trivago'>TRVG</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/NEON' title='Neonode, Inc.'>NEON</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CYRN' title='CYREN Ltd.'>CYRN</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/VJET' title='voxeljet AG'>VJET</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/MIME' title='Mimecast'>MIME</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OHGI' title='One Horizon Group, Inc.'>OHGI</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MIND' title='Mitcham Industries, Inc.'>MIND</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267398\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$TRVG $NEON $CYRN - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3267398-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3267398-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267396\" data-ts=\"1494874663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267396-arcelormittal-warns-bosnia-authorities-on-iron-ore-mine-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal warns Bosnia authorities on iron ore mine sale</a></h4><ul>     <li>ArcelorMittal (<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+3.2%</font>) warns Bosnia's authorities it is <a href=\"http://www.reuters.com/article/us-arcelormittal-bosnia-privatisation-idUSKCN18B1ZY\" target=\"_blank\">ready to take legal action</a> to protect its ownership rights if a government-owned stake in the Ljubija iron ore mine is sold to a rival bidder.</li>     <li>MT owns 35% in the mine, while the government of Bosnia's autonomous Serb Republic has a 65% stake in the mine, which has been put up for sale; MT has made a bid to buy out the entire stake but the government has decided to sell it to rival bidder Israeli Investment Group, which was said to offer a higher price for the stake and a promise of more investment.</li>     <li>MT says if the Ljubija mine is sold to a rival bidder, the nearby Zenica iron ore processing plant could switch to a different production system, which would not be suitable for the ore from Ljubija and lead to job losses.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267396\" data-linked=\"ArcelorMittal warns Bosnia authorities on iron ore mine sale\" data-tweet=\"$MT - ArcelorMittal warns Bosnia authorities on iron ore mine sale https://seekingalpha.com/news/3267396-arcelormittal-warns-bosnia-authorities-on-iron-ore-mine-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3267396-arcelormittal-warns-bosnia-authorities-on-iron-ore-mine-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267390\" data-ts=\"1494872869\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FENG\" target=\"_blank\">FENG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267390-phoenix-new-media-52-week-lows-after-revenue-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phoenix New Media at 52-week lows after revenue miss</a></h4><ul>   <li>Phoenix New Media (NYSE:<a href='https://seekingalpha.com/symbol/FENG' title='Phoenix New Media Limited'>FENG</a>) is <font color='red'>3.5% lower</font> and tapping 52-week lows after it missed revenue in its \"challenging\" Q1.</li>    <li>The company swung to a loss and faced \"continuing headwinds and changes in the Chinese advertising industry,\" said CEO Shuang Liu.</li>    <li>Net loss was 32.2M yuan (about $4.7M), vs. year-ago net income of 11.6M yuan. Non-GAAP net loss was 23.2M yuan.</li>    <li>Revenue breakout: Net ad revenues, 241.1M yuan, about $35M (down 11.2%); paid services revenues, 53.4M yuan, about $7.76M (up 3.6%).</li>    <li>For Q2, it's guiding to revenues of 362M-382M yuan -- about $52.5M-$55.4M, vs. consensus for about $54.5M -- with net ad revenues of 311M-326M yuan and services revenues of 51M-56M yuan.</li>    <li><a href=\"https://seekingalpha.com/pr/16832099-phoenix-new-media-reports-first-quarter-2017-unaudited-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3267390\" data-linked=\"Phoenix New Media at 52-week lows after revenue miss\" data-tweet=\"$FENG - Phoenix New Media at 52-week lows after revenue miss https://seekingalpha.com/news/3267390-phoenix-new-media-52-week-lows-after-revenue-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3267390-phoenix-new-media-52-week-lows-after-revenue-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267389\" data-ts=\"1494872346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267389-petrobras-wins-tax-ruling-from-2009-saving-1_6b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras wins tax ruling from 2009, saving $1.6B</a></h4><ul>     <li>Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='green'>+2.4%</font>) moves higher after a Brazilian appeals panel late Friday made a final ruling in favor of the company and will allow it to <a href=\"http://www.reuters.com/article/us-petrobras-tax-idUSKBN188333\" target=\"_blank\">deduct all production costs</a> for oil and natural gas from its 2009 federal taxes.</li>     <li>In setting a final tax liability of 5.8B reais ($1.87B), the Administrative Board of Tax Appeals saved PBR more than 5B reais ($1.62B), based on tax data from the company's most recent quarterly financial report.</li><li>PBR also is enjoying continued momentum from <a href=\"https://seekingalpha.com/news/3266753-petrobras-plus-3-percent-biggest-profit-two-years\" target=\"_blank\">last week&rsquo;s report</a> of a $1.4B Q1 net profit, the company's largest in two years, that lifted shares by 5%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267389\" data-linked=\"Petrobras wins tax ruling from 2009, saving $1.6B\" data-tweet=\"$PBR - Petrobras wins tax ruling from 2009, saving $1.6B https://seekingalpha.com/news/3267389-petrobras-wins-tax-ruling-from-2009-saving-1_6b?source=tweet\" data-url=\"https://seekingalpha.com/news/3267389-petrobras-wins-tax-ruling-from-2009-saving-1_6b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267388\" data-ts=\"1494871481\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DKS\" target=\"_blank\">DKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267388-dicks-earnings-expected-to-bring-in-volatility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dick&#39;s earnings expected to bring in volatility</a></h4><ul> <li>Dick's Sporting Goods (<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a> <font color='red'>-0.9%</font>) reports results before the bell tomorrow.</li> <li>Consensus estimates are for Q1 revenue of $1.83B, EPS of $0.54 and comparable sales growth of 3.6%. Consensus marks for FY18 are for revenue of $9.29B, EPS of $3.72 and comparable sales growth of 2% to 3%.</li> <li>RBC thinks the results already reported by some sporting goods firms suggest that Dick's picked up market share during the quarter.</li> <li>Bloomberg observes that recent options activity on DKS tip off a volatile +7% move up or down for shares after the numbers are spilled.</li> <li>Shares of Dick's are down 10.2% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267388\" data-linked=\"Dick&#39;s earnings expected to bring in volatility\" data-tweet=\"$DKS - Dick&#39;s earnings expected to bring in volatility https://seekingalpha.com/news/3267388-dicks-earnings-expected-to-bring-in-volatility?source=tweet\" data-url=\"https://seekingalpha.com/news/3267388-dicks-earnings-expected-to-bring-in-volatility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267386\" data-ts=\"1494871416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTGC\" target=\"_blank\">HTGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267386-investors-cheer-dropped-restructuring-plan-hercules-capital\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors cheer dropped restructuring plan at Hercules Capital</a></h4><ul><li>Hercules Capital (<a href='https://seekingalpha.com/symbol/HTGC' title='Hercules Capital, Inc.'>HTGC</a> <font color='green'>+6%</font>) today has managed to claw back about half of what it lost two weeks ago when it announced plans to move to an external management structure.</li><li>The catalyst for the gain was this <a href=\"https://seekingalpha.com/news/3267171-hercules-postpones-special-meeting-take-expanded-look-management-alternatives\" target=\"_blank\">morning's indefinite postponement</a> of the special meeting to vote on the plan while alternatives are studied. The battle isn't over though. CEO Manuel Henriquez doesn't sound like he's giving up on the idea: \"We continue to believe that externalization will build on our competitive advantages and position the Company for continued growth.\"</li><li>Wunderlich's Merrill Ross <a href=\"http://www.barrons.com/articles/hercules-capital-rebounds-after-dropping-plan-for-new-structure-1494864953\" target=\"_blank\">continues with a Hold ratin</a>g on Hercules, and believes there are better alternatives to the Henriquez plan. One she suggests would be the development of a registered investment advisor as a subsidiary of the BDC.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267386\" data-linked=\"Investors cheer dropped restructuring plan at Hercules Capital\" data-tweet=\"$HTGC - Investors cheer dropped restructuring plan at Hercules Capital https://seekingalpha.com/news/3267386-investors-cheer-dropped-restructuring-plan-hercules-capital?source=tweet\" data-url=\"https://seekingalpha.com/news/3267386-investors-cheer-dropped-restructuring-plan-hercules-capital\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267384\" data-ts=\"1494871321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267384-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TGB' title='Taseko Mines Limited'>TGB</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/SND' title='Smart Sand'>SND</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PKD-OLD' title='Parker Drilling Company'>PKD-OLD</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/GPRK' title='GeoPark Ltd.'>GPRK</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/FMSA' title='Fairmount Santrol, Inc.'>FMSA</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ASH' title='Ashland Inc.'>ASH</a> <font color='red'>-48%</font>. <a href='https://seekingalpha.com/symbol/WLB' title='Westmoreland Coal Co'>WLB</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AAU' title='Almaden Minerals Ltd'>AAU</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MTRX' title='Matrix Service Company'>MTRX</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267384\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$TGB $SND $PKD - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3267384-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3267384-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267382\" data-ts=\"1494870942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSC-OLD\" target=\"_blank\">SSC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267382-wecast-networkminus-3_7-after-swing-to-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wecast Network -3.7% after swing to profit</a></h4><ul>   <li>Wecast Network (WCST) is <font color='red'>off 3.7%</font> after a quarter of transformation where revenue increased more than 25-fold due to new business it took over at the beginning of the year.</li>    <li>Revenues were $33.2M (vs. a year-ago $1.3M), and cost of revenues -- mainly electronic product purchasing costs from Wecast Services -- was up to $29.3M.</li>    <li>Gross margin fell to 11.5% from 27.9% after the company shifted Wecast Services from its legacy You On Demand business.</li>    <li>The company moved its <a href=\"http://corporate.wecastnetworkinc.com/\" target=\"_blank\">conference call</a> to 4:15 p.m. today.</li>    <li>It's not guiding for Q2 but reiterates full-year revenue guidance for $300M.</li>    <li><a href=\"https://seekingalpha.com/pr/16832338-wecast-network-reports-q1-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3267382\" data-linked=\"Wecast Network -3.7% after swing to profit\" data-tweet=\"$SSC-OLD - Wecast Network -3.7% after swing to profit https://seekingalpha.com/news/3267382-wecast-networkminus-3_7-after-swing-to-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3267382-wecast-networkminus-3_7-after-swing-to-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267380\" data-ts=\"1494870127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHR\" target=\"_blank\">WHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267380-whirlpoolplus-2_8-on-strong-aham-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whirlpool +2.8% on strong AHAM data</a></h4><ul><li>According to the Association of Home Appliance Manufacturers, <a href=\"https://twitter.com/thenotablecalls/status/864164025248227329\" target=\"_blank\">April shipments of</a> washers, dryers, dishwashers, refrigerators, freezers, ranges, and ovens were up 13.7% year-over-year vs. expectations for about a 2% rise.</li><li><a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a>&nbsp;<font color='green'>+2.8%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3267380\" data-linked=\"Whirlpool +2.8% on strong AHAM data\" data-tweet=\"$WHR - Whirlpool +2.8% on strong AHAM data https://seekingalpha.com/news/3267380-whirlpoolplus-2_8-on-strong-aham-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3267380-whirlpoolplus-2_8-on-strong-aham-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267374\" data-ts=\"1494868278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267374-financials-top-5-gainers-losers-of-1-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:10 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OBAS' title='Optibase Ltd.'>OBAS</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/IHT' title='Innsuites Hospitality Trust'>IHT</a> <font color='green'>+11%</font>.<a href='https://seekingalpha.com/symbol/HTGC' title='Hercules Capital, Inc.'>HTGC</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/PIH' title='1347 Property Insurance Holdings, Inc.'>PIH</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/WETF' title='WisdomTree Investments, Inc.'>WETF</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267374\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:10 PM\" data-tweet=\"$OBAS $IHT $HTGC - Financials - Top 5 Gainers / Losers as of 1:10 PM https://seekingalpha.com/news/3267374-financials-top-5-gainers-losers-of-1-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3267374-financials-top-5-gainers-losers-of-1-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267372\" data-ts=\"1494868054\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMGN\" target=\"_blank\">IMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267372-immunogen-up-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoGen up 16%</a></h4><ul><li>ImmunoGen (<a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color='green'>+16.2%</font>) is up on more than a 60% spike in volume on no particular news. On Wednesday, ASCO abstracts will be released. Efficacy and safety data for mirvetuximab soravtansine are expected.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267372\" data-linked=\"ImmunoGen up 16%\" data-tweet=\"$IMGN - ImmunoGen up 16% https://seekingalpha.com/news/3267372-immunogen-up-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3267372-immunogen-up-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267373\" data-ts=\"1494868046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWER\" target=\"_blank\">TWER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267373-towerstreamplus-17_2-losses-narrow-on-cost-control\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Towerstream +17.2% as losses narrow on cost control</a></h4><ul>   <li>Towerstream (NASDAQ:<a href='https://seekingalpha.com/symbol/TWER-OLD' title='Towerstream Corporation'>TWER</a>) has built on early gains, <font color='green'>up 17.2%</font>, after <a href=\"https://seekingalpha.com/news/3267288-towerstream-reports-q1-results\" target=\"_blank\">Q1 earnings</a> where it narrowed losses thanks to additional \"right-sizing\" of its cost structure.</li>    <li>Revenues dipped slightly to $6.6M and EBITDA became positive, going from a loss of $2.42M to a gain of $245,000.</li>    <li>Churn fell to 1.39% from 1.65%, and ARPU increased to $550,000 from $525,000 (and was up 11% Q/Q).</li>    <li>Monthly recurring revenue of contracts signed rose 5% Y/Y (and 22% Q/Q) to $149,000.</li>    <li><a href=\"https://seekingalpha.com/pr/16832772-towerstream-reports-upon-first-quarter-results-2017-comments-key-performance-indicators\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3267373\" data-linked=\"Towerstream +17.2% as losses narrow on cost control\" data-tweet=\"$TWER $TWER-OLD - Towerstream +17.2% as losses narrow on cost control https://seekingalpha.com/news/3267373-towerstreamplus-17_2-losses-narrow-on-cost-control?source=tweet\" data-url=\"https://seekingalpha.com/news/3267373-towerstreamplus-17_2-losses-narrow-on-cost-control\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267371\" data-ts=\"1494867628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RARX\" target=\"_blank\">RARX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267371-ra-pharmaceuticals-up-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ra Pharmaceuticals up 18%</a></h4><ul><li>Thinly traded small cap Ra Pharmaceuticals (<a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals'>RARX</a> <font color='green'>+17.9%</font>) jumps on a 45% spike in volume. No particular news accounts for move. The company recently <a href=\"https://seekingalpha.com/pr/16831046-ra-pharmaceuticals-reports-first-quarter-2017-financial-results-provides-corporate-update\" target=\"_blank\">started </a>dosing in a Phase 2 clinical trial assessing lead candidate RA101495 in paroxysmal nocturnal hemoglobinuria &#40;PNH&#41;.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267371\" data-linked=\"Ra Pharmaceuticals up 18%\" data-tweet=\"$RARX - Ra Pharmaceuticals up 18% https://seekingalpha.com/news/3267371-ra-pharmaceuticals-up-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3267371-ra-pharmaceuticals-up-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267370\" data-ts=\"1494867541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVA\" target=\"_blank\">CVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267370-covanta-upgraded-baird-well-positioned-for-growth-dublin-comes-online\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Covanta upgraded at Baird; well positioned for growth as Dublin comes online</a></h4><ul><li>Covanta (<a href='https://seekingalpha.com/symbol/CVA' title='Covanta Holding Corporation'>CVA</a> <font color='green'>+2.9%</font>) is higher after Baird <a href=\"https://www.streetinsider.com/Analyst+Comments/Baird+Upgrades+Covanta+%28CVA%29+to+Outperform/12900525.html\" target=\"_blank\">upgrades</a> shares to Outperform from Neutral with a $17 price target, citing an attractive risk/reward profile.</li><li>Baird believes CVA is well positioned for growth, as the Dublin energy-to-waste facility should drive EBITDA expansion and higher free cash flow in 2018, and CVA's debt should be reduced as Dublin comes online.</li><li>The firm thinks CVA has an attractive risk/reward profile at current levels due to  the company's highly contracted and hedged revenue streams and strong  dividend.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267370\" data-linked=\"Covanta upgraded at Baird; well positioned for growth as Dublin comes online\" data-tweet=\"$CVA - Covanta upgraded at Baird; well positioned for growth as Dublin comes online https://seekingalpha.com/news/3267370-covanta-upgraded-baird-well-positioned-for-growth-dublin-comes-online?source=tweet\" data-url=\"https://seekingalpha.com/news/3267370-covanta-upgraded-baird-well-positioned-for-growth-dublin-comes-online\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267368\" data-ts=\"1494867027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXAS\" target=\"_blank\">EXAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267368-exact-chief-conroy-says-citron-dead-wrong\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exact chief Conroy says Citron &quot;dead wrong&quot;</a></h4><ul><li>Unsurprisingly, Exact Sciences' (<a href='https://seekingalpha.com/symbol/EXAS' title='EXACT Sciences Corporation'>EXAS</a> <font color='red'>-5.1%</font>) CEO Kevin Conroy says short seller Citron Research is \"dead wrong\" in its bearish assessment of Cologuard. He commented on the issue in an interview on CNBC today. He added that the price of the cancer screening test is \"stable.\"</li><li>Source: StreetInsider</li></ul><div class=\"tiny-share-widget\" data-id=\"3267368\" data-linked=\"Exact chief Conroy says Citron &quot;dead wrong&quot;\" data-tweet=\"$EXAS - Exact chief Conroy says Citron &quot;dead wrong&quot; https://seekingalpha.com/news/3267368-exact-chief-conroy-says-citron-dead-wrong?source=tweet\" data-url=\"https://seekingalpha.com/news/3267368-exact-chief-conroy-says-citron-dead-wrong\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267367\" data-ts=\"1494866769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267367-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CBMG' title='Cellular Biomedicine Group, Inc.'>CBMG</a> <font color='green'>+59%</font>. <a href='https://seekingalpha.com/symbol/PTHN' title='Patheon'>PTHN</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/TRVG' title='Trivago'>TRVG</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals'>RARX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CYRN' title='CYREN Ltd.'>CYRN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/HAYN' title='Haynes International, Inc.'>HAYN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/NEON' title='Neonode, Inc.'>NEON</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/SINO' title='Sino-Global Shipping America, Ltd.'>SINO</a> <font color='green'>+14%</font>.</li><li><b>Losers:&nbsp;</b><a href='https://seekingalpha.com/symbol/TOPS' title='TOP Ships Inc.'>TOPS</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/VRS' title='Verso Corporation'>VRS</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/FRTA' title='Forterra'>FRTA</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/PRTS' title='U.S. Auto Parts Network, Inc.'>PRTS</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/WLB' title='Westmoreland Coal Co'>WLB</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/OHGI' title='One Horizon Group, Inc.'>OHGI</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CCCL' title='China Ceramics Co., Ltd.'>CCCL</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/EVI' title='EnviroStar, Inc.'>EVI</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/AMS' title='American Shared Hospital Services'>AMS</a>&nbsp;<font color='red'>-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267367\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CBMG $PTHN $SORL - Midday Gainers / Losers https://seekingalpha.com/news/3267367-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3267367-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267357\" data-ts=\"1494864052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267357-cisco-gets-upgrade-to-buy-morgan-stanley-on-security-driven-trends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco gets upgrade to Buy at Morgan Stanley on security-driven trends</a></h4><ul>   <li>Cisco Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>) is <font color='green'>up 2.6%</font> today amid a Morgan Stanley upgrade to Overweight ahead of earnings.</li>    <li>The company's set to take advantage of a \"paradigm shift\" to security-defined networking, says analyst James Faucette, pointing to channel checks showing security sales pulling through equipment upgrades.</li>    <li>That <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/05/9462821/cisco-systems-offers-an-opportunity-to-invest-in-a-cyber\" target=\"_blank\">improves replacement cycle metrics</a>, he writes. &ldquo;Cisco continues to drive a mix shift towards software and recurring revenues, and in conjunction with strong firewall refresh activity, will gain share of IT budgets as customers increasingly favor Cisco&rsquo;s end-to-end portfolio and architecture to improve cybersecurity.&rdquo;</li>    <li>He's raised his price target on the stock to $39, from $32, implying 13.6% upside ahead.</li>    <li>Cisco is set to release earnings after the closing bell on Wednesday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267357\" data-linked=\"Cisco gets upgrade to Buy at Morgan Stanley on security-driven trends\" data-tweet=\"$CSCO - Cisco gets upgrade to Buy at Morgan Stanley on security-driven trends https://seekingalpha.com/news/3267357-cisco-gets-upgrade-to-buy-morgan-stanley-on-security-driven-trends?source=tweet\" data-url=\"https://seekingalpha.com/news/3267357-cisco-gets-upgrade-to-buy-morgan-stanley-on-security-driven-trends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267356\" data-ts=\"1494864016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267356-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VRS' title='Verso Corporation'>VRS</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267356\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SORL $CAAS $WKHS - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3267356-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3267356-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267355\" data-ts=\"1494863990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNC\" target=\"_blank\">GNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267355-gnc-holdings-new-long-shanda\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GNC Holdings a new long at Shanda</a></h4><ul><li>GNC Holdings (NYSE:<a href='https://seekingalpha.com/symbol/GNC' title='GNC Holdings, Inc.'>GNC</a>) is&nbsp;<font color='green'>up 1.71%</font>&nbsp;on moderate volume after Shanda Asset Management discloses that it added the stock as a new position in Q1.</li><li>The firm piled up just under 551K shares during the quarter.</li><li><a href=\"https://www.sec.gov/Archives/edgar/data/1622346/000095010317004575/xslForm13F_X01/infotable.xml\" target=\"_blank\">Shanda 13F filing</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3267355\" data-linked=\"GNC Holdings a new long at Shanda\" data-tweet=\"$GNC - GNC Holdings a new long at Shanda https://seekingalpha.com/news/3267355-gnc-holdings-new-long-shanda?source=tweet\" data-url=\"https://seekingalpha.com/news/3267355-gnc-holdings-new-long-shanda\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267354\" data-ts=\"1494863683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLB\" target=\"_blank\">WLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267354-westmoreland-coalminus-17-on-q1-results-sales-fall-4_5-y-y\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westmoreland Coal -17% on Q1 results; sales fall 4.5% Y/Y</a></h4><ul>     <li>Westmoreland Coal (<a href='https://seekingalpha.com/symbol/WLB' title='Westmoreland Coal Co'>WLB</a> <font color='red'>-17.5%</font>) plunges as much as 26% after reporting a <a href=\"https://seekingalpha.com/news/3267218-westmoreland-coal-eps-1_98\" target=\"_blank\">Q1 net loss</a> of $1.98/share vs. a $1.67 profit a year ago, with the company blaming a 4.5% Y/Y decrease in sales mostly on the expiration of the Jewett and Beulah coal supply contracts.</li><li>WLB also cites operational challenges, including dragline repairs in Canada and  temporary mining in a lower-yield area of certain mines, in driving lower sales and higher costs.</li>     <li>WLB <a href=\"http://247wallst.com/energy-business/2017/05/15/westmoreland-coal-earnings-and-the-troubles-ahead-for-coal/\" target=\"_blank\">maintains FY 2017 guidance</a> of 40M-50M coal tons sales and adjusted EBITDA of $280M-$310M; Q1 coal shipments fell 10% Y/Y but adjusted EBITDA rose 39%, primarily due to an early repayment of loan and lease receivables totaling $47M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267354\" data-linked=\"Westmoreland Coal -17% on Q1 results; sales fall 4.5% Y/Y\" data-tweet=\"$WLB - Westmoreland Coal -17% on Q1 results; sales fall 4.5% Y/Y https://seekingalpha.com/news/3267354-westmoreland-coalminus-17-on-q1-results-sales-fall-4_5-y-y?source=tweet\" data-url=\"https://seekingalpha.com/news/3267354-westmoreland-coalminus-17-on-q1-results-sales-fall-4_5-y-y\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267341\" data-ts=\"1494861921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXAS\" target=\"_blank\">EXAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267341-citron-bearish-on-exact-sciences-sees-single-digit-valuation-shares-off-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron bearish on Exact Sciences, sees single-digit valuation; shares off 6%</a></h4><ul><li>Noted short seller Citron Research has Exact Sciences (<a href='https://seekingalpha.com/symbol/EXAS' title='EXACT Sciences Corporation'>EXAS</a> <font color='red'>-6%</font>) in its crosshairs. It predicts that the provider of the Cologuard cancer test has almost a 40% downside in the short term and up to 70% or more over the next few years.</li><li>In its just-released <a href=\"http://www.citronresearch.com/wp-content/uploads/2017/05/exas-final-a.pdf\" target=\"_blank\">report</a>, Citron says Cologuard, which accounts for all of the company's sales, is inferior to the fecal immunochemical test &#40;FIT&#41; and colonoscopy while being more expensive, assuming equal participation rates (study <a href=\"http://www.gastrojournal.org/article/S0016-5085%2816%2934617-0/abstract\" target=\"_blank\">published </a>in the journal <em>Gastroenterology&nbsp;</em>last year).</li><li>Citron also cites an anemic reorder rate from doctors and a looming cut in Medicare reimbursement from $512 to as low as $285.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267341\" data-linked=\"Citron bearish on Exact Sciences, sees single-digit valuation; shares off 6%\" data-tweet=\"$EXAS - Citron bearish on Exact Sciences, sees single-digit valuation; shares off 6% https://seekingalpha.com/news/3267341-citron-bearish-on-exact-sciences-sees-single-digit-valuation-shares-off-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3267341-citron-bearish-on-exact-sciences-sees-single-digit-valuation-shares-off-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>110&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267339\" data-ts=\"1494861301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRVG\" target=\"_blank\">TRVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267339-trivagoplus-13_6-to-new-high-swings-to-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trivago +13.6% to new high as it swings to profit</a></h4><ul>   <li>Trivago (NASDAQ:<a href='https://seekingalpha.com/symbol/TRVG' title='Trivago'>TRVG</a>) is <font color='green'>up 13.6%</font> and tagging new 52-week highs after revenues rose by two-thirds and the company swung to a net profit in <a href=\"https://seekingalpha.com/news/3267175-trivago-eps-line-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li>    <li>EBITDA rose 151% to &euro;19.3M, beating an expected &euro;12.5M. Net income rose to &euro;7.7M vs. a year-ago loss of &euro;0.1M.</li>    <li>Qualified referrals rose 60% to 177.2M; revenue per qualified referral was up 4%, to &euro;1.49.</li>    <li>Referral revenue by geography: Americas, &euro;102.2M (up 77%); Developed Europe, &euro;113.5M (up 44%); Rest of World, &euro;48.6M (up 128%).</li>    <li>Revenue per qualified referral by geo: Americas, &euro;1.84 (up 7%); Developed Europe, &euro;1.54 (up 6%); Rest of World, &euro;1.01 (up 6%).</li>    <li><a href=\"https://seekingalpha.com/pr/16832266-trivago-n-v-reports-first-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3267339\" data-linked=\"Trivago +13.6% to new high as it swings to profit\" data-tweet=\"$TRVG - Trivago +13.6% to new high as it swings to profit https://seekingalpha.com/news/3267339-trivagoplus-13_6-to-new-high-swings-to-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3267339-trivagoplus-13_6-to-new-high-swings-to-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267309\" data-ts=\"1494860431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267309-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CBMG' title='Cellular Biomedicine Group, Inc.'>CBMG</a> <font color='green'>+71%</font>. <a href='https://seekingalpha.com/symbol/PTHN' title='Patheon'>PTHN</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/NK' title='NantKwest'>NK</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/AMS' title='American Shared Hospital Services'>AMS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/EGRX' title='Eagle Pharmaceuticals Inc.'>EGRX</a> <font color='red'>-11%</font>. TPIV <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267309\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$CBMG $PTHN $ALNY - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3267309-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3267309-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267330\" data-ts=\"1494859676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SINO\" target=\"_blank\">SINO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267330-sino-global-shipping-america-reports-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sino-Global Shipping America reports Q3 results</a></h4><ul><li>Sino-Global Shipping America (NASDAQ:<a href='https://seekingalpha.com/symbol/SINO' title='Sino-Global Shipping America, Ltd.'>SINO</a>): Q3 EPS of $0.14</li><li>Revenue of $2.75M (+135.0% Y/Y)</li><li>Shares <font color='green'>+17%</font>.</li><li><a href='https://seekingalpha.com/pr/16833018-sino-global-announces-fiscal-year-2017-third-quarter-financial-results-highlighted-134_1'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3267330\" data-linked=\"Sino-Global Shipping America reports Q3 results\" data-tweet=\"$SINO - Sino-Global Shipping America reports Q3 results https://seekingalpha.com/news/3267330-sino-global-shipping-america-reports-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3267330-sino-global-shipping-america-reports-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267329\" data-ts=\"1494859367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EKSO\" target=\"_blank\">EKSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267329-ekso-higher-ceo-talks-to-cnbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ekso higher as CEO talks to CNBC</a></h4><ul><li><b>Beck Quick:</b> Is [exoskeleton robot legs] covered by rehab?</li><li><b>CEO Thomas Looby:</b> It's covered in the clinic. What we want to do is work on and enhance that reimbursement because it's high technology and we think the outcomes are there. We need to go and demonstrate that with larger patient co-boards to the payers, so they can cover those things with additional coverage.</li><li><b>Beck Quick:</b> How did you come up with this idea?</li><li><b>CEO Thomas Looby:</b> There's a large portfolio that Exso Bionics (<a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='green'>+7.4%</font>) has. We're deploying it in two markets right now: healthcare and workers on construction sites and the assembly line.</li><li>Check out the full clip <a href=\"http://app.criticalmention.com/app/#clip/view/27319503?token=d4fa516e-d1c8-420e-b9b9-d7fe30c61b2e\" target=\"_blank\">here</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3267329\" data-linked=\"Ekso higher as CEO talks to CNBC\" data-tweet=\"$EKSO - Ekso higher as CEO talks to CNBC https://seekingalpha.com/news/3267329-ekso-higher-ceo-talks-to-cnbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3267329-ekso-higher-ceo-talks-to-cnbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267324\" data-ts=\"1494859104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBMG\" target=\"_blank\">CBMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267324-cellular-bio-up-84-on-expansion-of-car-t-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellular Bio up 84% on expansion of CAR-T study</a></h4><ul><li>Thinly traded micro cap Cellular Biomedicine (<a href='https://seekingalpha.com/symbol/CBMG' title='Cellular Biomedicine Group, Inc.'>CBMG</a> <font color='green'>+84%</font>) has regained all of Friday's ~46% drop and then some. Shares are up on more than a 6x surge in volume on the heels of its <a href=\"https://seekingalpha.com/pr/16832235-cellular-biomedicine-group-cbmg-announces-addition-second-clinical-site-expansion-chimeric\" target=\"_blank\">announcement </a>that it has added a second site to its Phase 1 clinical trial assessing of CAR-T candidate C-CAR011 in patients with relapsed/refractory B cell non-Hodgkin lymphoma. Target enrollment in the study, called CARD-1, is 15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267324\" data-linked=\"Cellular Bio up 84% on expansion of CAR-T study\" data-tweet=\"$CBMG - Cellular Bio up 84% on expansion of CAR-T study https://seekingalpha.com/news/3267324-cellular-bio-up-84-on-expansion-of-car-t-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3267324-cellular-bio-up-84-on-expansion-of-car-t-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267325\" data-ts=\"1494859048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267325-biogen-70-upside-piper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen has 70% upside - Piper</a></h4><ul><li><a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">via Notable Calls</a></li><li>Noting the read-through for aducanumab <a href=\"https://seekingalpha.com/news/3267226-ionis-pharmas-inotersen-successful-late-stage-fap-study-side-effects-pressure-shares-10\" target=\"_blank\">from Ionis Pharma's</a> TTR Neuropathy data this morning, Piper is out with a whopping $110 price target hike for Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='green'>+1.2%</font>) to $442.</li><li>Though the&nbsp;aducanumab data readout isn't coming until 2020, Piper thinks there's a 50/50 chance of success, and that - combined with 50% ownership of the asset - is incredibly valuable no matter what happens to the MS franchise.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267325\" data-linked=\"Biogen has 70% upside - Piper\" data-tweet=\"$BIIB - Biogen has 70% upside - Piper https://seekingalpha.com/news/3267325-biogen-70-upside-piper?source=tweet\" data-url=\"https://seekingalpha.com/news/3267325-biogen-70-upside-piper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267323\" data-ts=\"1494858320\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267323-credit-suisse-dials-up-caution-on-lululemon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse dials up caution on Lululemon</a></h4><ul> <li>Lululemon (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) is&nbsp;<font color='red'>down 1.32%</font>&nbsp;after Credit Suisse warns on a rough finish to FQ1 for the retailer.</li> <li>The firm's channel checks showed a higher level of online markdown activity in April than a year ago. Lululemon already <a href=\"https://seekingalpha.com/news/3254270-tailspin-lululemon-warning-slow-start-2017\" target=\"_blank\">cautioned</a> that the early part of Q1 saw some weak sales trends.</li> <li>Shares of Lululemon are down 19% YTD and trade at 22.2X the high end of the company's full-year EPS guidance.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3267323\" data-linked=\"Credit Suisse dials up caution on Lululemon\" data-tweet=\"$LULU - Credit Suisse dials up caution on Lululemon https://seekingalpha.com/news/3267323-credit-suisse-dials-up-caution-on-lululemon?source=tweet\" data-url=\"https://seekingalpha.com/news/3267323-credit-suisse-dials-up-caution-on-lululemon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267317\" data-ts=\"1494857523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPR\" target=\"_blank\">TPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267317-deutsche-bank-positive-on-coach-kate-spade-in-bag\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank positive on Coach with Kate Spade in the bag</a></h4><ul> <li>Coach (COH <font color='green'>+1.3%</font>) trades higher after Deutsche Bank upgrades the retailer to Buy from Hold.</li> <li>The firm expresses confidence that Coach management can squeeze out large accretion benefits from the Kate Spade acquisition.</li> <li>The new price target on Coach from DB is $54 to rep 20% upside potential for shares.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3267317\" data-linked=\"Deutsche Bank positive on Coach with Kate Spade in the bag\" data-tweet=\"$TPR - Deutsche Bank positive on Coach with Kate Spade in the bag https://seekingalpha.com/news/3267317-deutsche-bank-positive-on-coach-kate-spade-in-bag?source=tweet\" data-url=\"https://seekingalpha.com/news/3267317-deutsche-bank-positive-on-coach-kate-spade-in-bag\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267316\" data-ts=\"1494857472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDGS\" target=\"_blank\">MDGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267316-medigus-nabs-patents-in-japan-and-europe-covering-scoutcam-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medigus nabs patents in Japan and Europe covering ScoutCam; shares up 9%</a></h4><ul><li>The Japanese Patent Office &nbsp;and the European Patent Office<a href=\"https://seekingalpha.com/pr/16832292-medigus-announces-japanese-european-patents-micro-scoutcam-tm-microvisual-technology\" target=\"_blank\"> issue patents</a> to Medigus (<a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd'>MDGS</a> <font color='green'>+8.8%</font>) covering its micro ScoutCam miniature camera technology.</li><li>The ScoutCam portfolio includes a range of video cameras with small diameter heads that use CMOS (complementary metal oxide semiconductor)- or CCD (charge-coupled device)-based sensors.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267316\" data-linked=\"Medigus nabs patents in Japan and Europe covering ScoutCam; shares up 9%\" data-tweet=\"$MDGS - Medigus nabs patents in Japan and Europe covering ScoutCam; shares up 9% https://seekingalpha.com/news/3267316-medigus-nabs-patents-in-japan-and-europe-covering-scoutcam-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3267316-medigus-nabs-patents-in-japan-and-europe-covering-scoutcam-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267307\" data-ts=\"1494856353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GDEN\" target=\"_blank\">GDEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267307-suntrust-downgrades-golden-entertainment-on-valuation-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunTrust downgrades Golden Entertainment on valuation call</a></h4><ul> <li>Golden Entertainment (<a href='https://seekingalpha.com/symbol/GDEN' title='Golden Entertainment, Inc.'>GDEN</a> <font color='red'>-5.1%</font>) tumbles after SunTrust <a href=\"https://twitter.com/Briefingcom/status/864074550941696000\" target=\"_blank\">reduces</a> the casino stock to a Hold rating. The Nevada-based company was lined up previosuly by Suntrust at Buy.</li> <li>The investment firm backs away due to concerns on valuation after watching Golden Entertainment go on a 41% YTD tear.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3267307\" data-linked=\"SunTrust downgrades Golden Entertainment on valuation call\" data-tweet=\"$GDEN - SunTrust downgrades Golden Entertainment on valuation call https://seekingalpha.com/news/3267307-suntrust-downgrades-golden-entertainment-on-valuation-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3267307-suntrust-downgrades-golden-entertainment-on-valuation-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267299\" data-ts=\"1494854933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VJET\" target=\"_blank\">VJET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267299-voxeljetplus-4_1-cowen-boosts-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Voxeljet +4.1% as Cowen boosts to Outperform</a></h4><ul>   <li>Voxeljet (NYSE:<a href='https://seekingalpha.com/symbol/VJET' title='voxeljet AG'>VJET</a>) is <font color='green'>up 4.1%</font> premarket after some post-earnings analyst moves.</li>    <li>Cowen boosted the stock to Outperform and raised its price target to $5.50 from $3, implying 35% upside.</li>    <li>Shares rode high Thursday after the company <a href=\"https://seekingalpha.com/news/3266706-voxeljet-marks-beat-revenue-narrower-loss\" target=\"_blank\">narrowed its losses</a> with revenue numbers that beat expectations with the help of service sales up more than a third.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267299\" data-linked=\"Voxeljet +4.1% as Cowen boosts to Outperform\" data-tweet=\"$VJET - Voxeljet +4.1% as Cowen boosts to Outperform https://seekingalpha.com/news/3267299-voxeljetplus-4_1-cowen-boosts-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3267299-voxeljetplus-4_1-cowen-boosts-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267298\" data-ts=\"1494854801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RXDX\" target=\"_blank\">RXDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267298-ignytas-entrectinib-breakthrough-therapy-for-certain-treatment-resistant-solid-tumors-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ignyta&#39;s entrectinib a Breakthrough Therapy for certain treatment-resistant solid tumors; shares ahead 10% premarket</a></h4><ul><li>Ignyta (NASDAQ:<a href='https://seekingalpha.com/symbol/RXDX' title='Ignyta, Inc.'>RXDX</a>) is up&nbsp;<font color='green'>10%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16832296-ignyta-granted-breakthrough-therapy-designation-entrectinib-u-s-food-drug-administration\" target=\"_blank\">announcement </a>that the FDA has designated entrectinib a Breakthrough Therapy for the treatment adult and pediatric patients with NTRK fusion-positive, locally advanced or metastatic solid tumors who have either progressed following prior treatment or who have no reasonable therapeutic options.</li><li>Breakthrough Therapy status provides for more intensive guidance from the FDA, the involvement of more senior agency personnel and a rolling review of the New Drug Application &#40;NDA&#41;.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267298\" data-linked=\"Ignyta&#39;s entrectinib a Breakthrough Therapy for certain treatment-resistant solid tumors; shares ahead 10% premarket\" data-tweet=\"$RXDX - Ignyta&#39;s entrectinib a Breakthrough Therapy for certain treatment-resistant solid tumors; shares ahead 10% premarket https://seekingalpha.com/news/3267298-ignytas-entrectinib-breakthrough-therapy-for-certain-treatment-resistant-solid-tumors-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3267298-ignytas-entrectinib-breakthrough-therapy-for-certain-treatment-resistant-solid-tumors-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267291\" data-ts=\"1494854381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDXG\" target=\"_blank\">IDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267291-interpace-q1-top-line-up-14-earnings-up-150-cash-flow-down-5-shares-ahead-21-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interpace Q1 top line up 14%; earnings up 150%; cash flow down 5%; shares ahead 21% premarket</a></h4><ul><li>Interpace Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a>) <a href=\"https://seekingalpha.com/pr/16832581-interpace-diagnostics-group-reports-first-quarter-2017-financial-results-business-progress\" target=\"_blank\">Q1 results</a> ($M): Revenue: 3.5 (+14.3%).</li><li>Net Income: 2.4 (+150.4%); EPS: 0.55 (+120.4%); Cash Flow Ops: (4.1) (-4.5%); Quick Assets: 7.1 (+999%).</li><li>Raised over $14M in new capital in the quarter, eliminated over $9.3M in secured debt.</li><li>Shares up&nbsp;<font color='green'>21%</font>&nbsp;premarket on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267291\" data-linked=\"Interpace Q1 top line up 14%; earnings up 150%; cash flow down 5%; shares ahead 21% premarket\" data-tweet=\"$IDXG - Interpace Q1 top line up 14%; earnings up 150%; cash flow down 5%; shares ahead 21% premarket https://seekingalpha.com/news/3267291-interpace-q1-top-line-up-14-earnings-up-150-cash-flow-down-5-shares-ahead-21-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3267291-interpace-q1-top-line-up-14-earnings-up-150-cash-flow-down-5-shares-ahead-21-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267282\" data-ts=\"1494853902\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267282-wall-street-majors-reel-in-expectations-on-tesla\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wall Street majors reel in expectations on Tesla</a></h4><ul> <li>Morgan Stanley analyst Adam Jonas downgrades Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) to Equalweight from Overweight on an increased view over risk at the stock's current level.</li> <li>Over the long-term, Jonas warns on the difficulty in Tesla going head-to-head against the Apple and Amazon ecosystems, while over the shorter haul the analyst now sees Tesla as reporting GAAP losses until late into 2019.</li><li>Other issues of concern addressed in the note are the upside in China for Tesla and questions on if adjacent business potential (trucks, solar, storage) is enough to justify valuation.</li> <li>Jonas also has a Model 3 production forecast below consensus. \"Looking to 2018, we believe our 90k volume forecast is also far below Street expectations, possibly one-half or one-third market expectations for Model 3 volume next year,\" writes the analyst.</li> <li>The new price target on Tesla from MS is $305.</li> <li>More analyst action: Goldman Sachs (Sell, $190 PT) cut its Q2 deliveries forecast by 1K on potential China demand-pull forward after meeting with management.</li> <li>Despite today's chippiness from Wall Street, positive ratings on the EV automaker still outnumber the sell calls.</li><li>Sources: Bloomberg and <a href=\"https://www.streetinsider.com/Analyst+Comments/Morgan+Stanley+Downgrades+Tesla+Motors+%28TSLA%29+to+Equalweight%3B+Lays+out+5+Changes+to+Justify+Downgrade/12900532.html\" target=\"_blank\">StreetInsider.com</a></li>  <li>TSLA <font color='red'>-2.04%</font> premarket to $318.20. Shares are up 52% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267282\" data-linked=\"Wall Street majors reel in expectations on Tesla\" data-tweet=\"$TSLA - Wall Street majors reel in expectations on Tesla https://seekingalpha.com/news/3267282-wall-street-majors-reel-in-expectations-on-tesla?source=tweet\" data-url=\"https://seekingalpha.com/news/3267282-wall-street-majors-reel-in-expectations-on-tesla\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>87&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267281\" data-ts=\"1494853876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267281-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a>&nbsp;<font color='red'>-6%</font>&nbsp;in <a href=\"https://seekingalpha.com/news/3267226-ionis-pharmas-inotersen-successful-late-stage-fap-study-side-effects-pressure-shares-10\" target=\"_blank\">response</a> to the side effects of inotersen.</li><li><a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16832760-dryships-inc-announces-successful-delivery-second-aframax-tanker\" target=\"_blank\">announcing</a> delivery of second Aframax &nbsp;tanker.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3267281\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$IONS $DRYS - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3267281-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3267281-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267279\" data-ts=\"1494853755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOLD\" target=\"_blank\">FOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267279-amicus-atb200-at2221-shows-treatment-effect-in-early-stage-pompe-study-shares-ahead-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amicus&#39; ATB200/AT2221 shows treatment effect in early-stage Pompe study; shares ahead 7% premarket</a></h4><ul><li>Amicus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a>) perks up&nbsp;<font color='green'>7%</font>&nbsp;premarket, albeit on only 1,350 shares, in response to its <a href=\"https://seekingalpha.com/pr/16832323-amicus-therapeutics-announces-positive-functional-data-initial-patients-pompe-phase-1-2-study\" target=\"_blank\">announcement </a>of positive results from an open-label Phase 1/2 clinical trial assessing ATB200/AT2221 in patients with an inherited lysosomal storage disorder called <a href=\"https://ghr.nlm.nih.gov/condition/pompe-disease\" target=\"_blank\">Pompe disease</a>.</li><li>Patients who completed six months of treatment showed improvement in motor function, including the six-minute walk test, and stability or improvements in lung function as measured by forced vital capacity. In addition, patients treated with ATB200/AT2221 continue to show improvements in biomarkers related to muscle damage and disease substrate.</li><li><a href=\"http://amicusrx.com/pompe_disease.php\" target=\"_blank\">ATB200/AT2221</a> is a new treatment paradigm consisting of ATB200, a recombinant human enzyme called acid alpha-glucosidase with enhanced uptake characteristics and AT2221, a pharmacological chaperone.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267279\" data-linked=\"Amicus&#39; ATB200/AT2221 shows treatment effect in early-stage Pompe study; shares ahead 7% premarket\" data-tweet=\"$FOLD - Amicus&#39; ATB200/AT2221 shows treatment effect in early-stage Pompe study; shares ahead 7% premarket https://seekingalpha.com/news/3267279-amicus-atb200-at2221-shows-treatment-effect-in-early-stage-pompe-study-shares-ahead-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3267279-amicus-atb200-at2221-shows-treatment-effect-in-early-stage-pompe-study-shares-ahead-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267271\" data-ts=\"1494853191\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYRN\" target=\"_blank\">CYRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267271-cyrenplus-32_5-after-wannacry-cyberattack\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cyren +32.5% after the WannaCry cyberattack</a></h4><ul><li><a href=\"https://seekingalpha.com/news/3267126-wannacry-puts-focus-cybersecurity-stocks\" target=\"_blank\">As reported here</a>, the cybersecurity names are all on the move this morning as the world digests last week's WannaCry ransomware attack, and mulls the odds of a second wave.</li><li>Moving the most is tiny Cyren (NASDAQ:<a href='https://seekingalpha.com/symbol/CYRN' title='CYREN Ltd.'>CYRN</a>),&nbsp;<font color='green'>up 32.5%</font>&nbsp;on sizable volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267271\" data-linked=\"Cyren +32.5% after the WannaCry cyberattack\" data-tweet=\"$CYRN - Cyren +32.5% after the WannaCry cyberattack https://seekingalpha.com/news/3267271-cyrenplus-32_5-after-wannacry-cyberattack?source=tweet\" data-url=\"https://seekingalpha.com/news/3267271-cyrenplus-32_5-after-wannacry-cyberattack\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267263\" data-ts=\"1494852580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDXG\" target=\"_blank\">IDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267263-interpace-diagnostics-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interpace Diagnostics reports Q1 results</a></h4><ul><li>Interpace Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a>): Q1 EPS of $0.42</li><li>Revenue of $3.47M (+14.1% Y/Y)</li><li>Shares <font color='green'>+23.43%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16832581-interpace-diagnostics-group-reports-first-quarter-2017-financial-results-business-progress'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3267263\" data-linked=\"Interpace Diagnostics reports Q1 results\" data-tweet=\"$IDXG - Interpace Diagnostics reports Q1 results https://seekingalpha.com/news/3267263-interpace-diagnostics-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3267263-interpace-diagnostics-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267261\" data-ts=\"1494852248\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SORL\" target=\"_blank\">SORL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267261-sorl-auto-races-to-multi-year-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SORL Auto races to multi-year high</a></h4><ul> <li>Shares of SORL Auto Parts (NASDAQ:<a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a>) <font color='green'>jump 25%</font> on moderate premarket trading volume.</li> <li>Execs say that the company has gained traction after the stricter emissions regulations put down by the Chinese government on overloading in the truck market. Cost-cutting initiatives are also paying off.</li> <li>SORL is at a multi-year high in the premarket session.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3267137-sorl-auto-reports-q1-results\" target=\"_blank\">SORL Auto reports Q1 results</a> (May 15)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3267155-sorl-autos-q1\" target=\"_blank\">More on SORL Auto's Q1</a> (May 15)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3267261\" data-linked=\"SORL Auto races to multi-year high\" data-tweet=\"$SORL - SORL Auto races to multi-year high https://seekingalpha.com/news/3267261-sorl-auto-races-to-multi-year-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3267261-sorl-auto-races-to-multi-year-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267254\" data-ts=\"1494851939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267254-bhp-to-drop-billiton-from-name-part-of-rebranding-effort\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BHP to drop Billiton from its name as part of rebranding effort</a></h4><ul><li>BHP Billiton (NYSE:<a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a>) is launching a <a href=\"http://www.bhpbilliton.com/media-and-insights/news-releases/2017/05/bhp-launches-think-big-brand-campaign\" target=\"_blank\">global rebranding</a> that will include dropping \"Billiton\" from its name and changing its logo, as it seeks to improve its public image.</li><li>Company officials say that since the global financial crisis, BHP has <a href=\"http://www.smh.com.au/business/mining-and-resources/bhp-to-drop-billiton-in-rebranding-move-20170514-gw4dfz.html\" target=\"_blank\">encountered rising skepticism</a> over the role of big companies  in the economy, as well as the public debate over the Australian government's introduction of a mining resource tax, and more recently  the Samarco dam failure in Brazil.</li><li>The campaign comes in the wake of a push by activist investor Elliott  Management to force BHP to collapse its dual listed structure and to spin off some of its North American assets, although company  officials say rebranding plans have been in the works for 18 months.</li><li>BHP&nbsp;<font color='green'>+1.8%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267254\" data-linked=\"BHP to drop Billiton from its name as part of rebranding effort\" data-tweet=\"$BHP - BHP to drop Billiton from its name as part of rebranding effort https://seekingalpha.com/news/3267254-bhp-to-drop-billiton-from-name-part-of-rebranding-effort?source=tweet\" data-url=\"https://seekingalpha.com/news/3267254-bhp-to-drop-billiton-from-name-part-of-rebranding-effort\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267242\" data-ts=\"1494851448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSYS\" target=\"_blank\">SSYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267242-stratasys-pauses-big-run-after-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stratasys pauses big run after downgrade</a></h4><ul><li>The stock's&nbsp;<font color='green'>81% gain</font>&nbsp;this year likely has priced in expectations for strong growth and margin expansion, says William Blair's Brian Drab, downgrading Stratasys (NASDAQ:<a href='https://seekingalpha.com/symbol/SSYS' title='Stratasys, Inc.'>SSYS</a>) to Underperform from Market Perform.</li><li>He notes the company's 3% organic revenue decline last year vs. the 3D industry's 17% growth suggests Stratasys is losing market share - not surprising given the wave of new players entering the market.</li><li>Source: Bloomberg</li><li>Shares&nbsp;<font color='red'>down 3.6%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3267242\" data-linked=\"Stratasys pauses big run after downgrade\" data-tweet=\"$SSYS - Stratasys pauses big run after downgrade https://seekingalpha.com/news/3267242-stratasys-pauses-big-run-after-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3267242-stratasys-pauses-big-run-after-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267234\" data-ts=\"1494850586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMTD\" target=\"_blank\">AMTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267234-amertirade-upgraded-wells-fargo-on-scottrade-dealplus-1_3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amertirade upgraded at Wells Fargo on Scottrade deal; +1.3% premarket</a></h4><ul><li>via Bloomberg</li><li>There are \"quite a few ways to win\" from the Scottrade purchase, says analyst Chris Harris, upgrading TD Ameritrade (NASDAQ:<a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a>) to Outperform from Market Perform.</li><li>Harris and team's model sees 30% EPS accretion, double what Ameritrade is forecasting. How's that? Scottrade revenue is coming in significantly higher than expected, as are interest rates and customer asset levels.</li><li>As for commission cuts, he doesn't see any more coming as Schwab has other priorities, and Ameritrade's rates are now inline with Fidelity.</li><li>Harris' $44 price target suggests&nbsp;<font color='green'>18% upside</font>.</li><li>Shares&nbsp;<font color='green'>+1.3%</font>&nbsp;premarket to $37.80</li></ul><div class=\"tiny-share-widget\" data-id=\"3267234\" data-linked=\"Amertirade upgraded at Wells Fargo on Scottrade deal; +1.3% premarket\" data-tweet=\"$AMTD - Amertirade upgraded at Wells Fargo on Scottrade deal; +1.3% premarket https://seekingalpha.com/news/3267234-amertirade-upgraded-wells-fargo-on-scottrade-dealplus-1_3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3267234-amertirade-upgraded-wells-fargo-on-scottrade-dealplus-1_3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267231\" data-ts=\"1494850423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAL\" target=\"_blank\">UAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267231-united-continental-cockpit-access-codes-leaked\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Continental cockpit access codes leaked</a></h4><ul> <li>Access codes for the cockpit doors of United Continental (NASDAQ:<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a>) planes were accidentally posted <a href=\"https://techcrunch.com/2017/05/14/access-codes-for-united-cockpit-doors-accidentally-posted-online/\" target=\"_blank\">online</a> by a flight attendant.</li> <li>No issues on the flight deck of UAL planes have been reported to be caused by the security breach.</li><li>The Air Line Pilots Association says the problem has been fixed.</li> <li>UAL <font color='red'>-0.84%</font> premarket to $75.77.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3267231\" data-linked=\"United Continental cockpit access codes leaked\" data-tweet=\"$UAL - United Continental cockpit access codes leaked https://seekingalpha.com/news/3267231-united-continental-cockpit-access-codes-leaked?source=tweet\" data-url=\"https://seekingalpha.com/news/3267231-united-continental-cockpit-access-codes-leaked\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267227\" data-ts=\"1494850305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NE\" target=\"_blank\">NE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267227-energy-stocks-lead-way-saudi-russia-oil-agreement-lifts-crude-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy stocks lead the way as Saudi-Russia oil agreement lifts crude 3%</a></h4><ul>     <li>Energy stocks ramp up as the Saudi and Russian energy ministers say they are in favor of <a href=\"https://seekingalpha.com/news/3267124-oil-jumps-supply-cut-chatter\" target=\"_blank\">extending the deal to cut production</a> for nine months until next March.</li><li>The proposed deal, which <a href=\"https://www.bloomberg.com/news/articles/2017-05-15/oil-halts-gains-as-more-u-s-rigs-counter-opec-cut-deal-report\" target=\"_blank\">still must be confirmed</a> when OPEC meets in Vienna on May 25, would extend the cuts beyond the original June 2017 expiration and goes  beyond the possible six-month extension originally contemplated.</li><li>U.S. crude oil <font color='green'>+3%</font> at $49.27/bbl, while Brent <font color='green'>+2.9%</font> at $52.34/bbl.</li><li>Oil and gas companies dominate the list of premarket gainers: <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color='green'>+8.6%</font>, <a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a> <font color='green'>+7.7%</font>, <a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a> <font color='green'>+5.6%</font>, <a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a> <font color='green'>+5.4%</font>, <a href='https://seekingalpha.com/symbol/ATW' title='Atwood Oceanics Inc.'>ATW</a> <font color='green'>+4.9%</font>, <a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color='green'>+4.4%</font>, <a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International Ltd.'>WFT</a> <font color='green'>+4.2%</font>, <a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color='green'>+4.1%</font>,  <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='green'>+3.4%</font>,  <a href='https://seekingalpha.com/symbol/OAS' title='Oasis Petroleum Inc.'>OAS</a> <font color='green'>+3.3%</font>, <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='green'>+3.2%,</font> <a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='green'>+2.1%</font>,  <a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> <font color='green'>+2%</font>,  <a href='https://seekingalpha.com/symbol/TOT' title='TOTAL S.A.'>TOT</a> <font color='green'>+2%</font>, <a href='https://seekingalpha.com/symbol/RDS.A' title='Royal Dutch Shell plc'>RDS.A</a> <font color='green'>+1.8%</font>,  <a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='green'>+1.7%</font>, <a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a> <font color='green'>+1.6%</font>,  <a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color='green'>+1.5%</font>, <a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color='green'>+1.4%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/IEZ' title='iShares U.S. Oil Equipment & Services ETF'>IEZ</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>, <a href='https://seekingalpha.com/symbol/PXI' title='Invesco DWA Energy Momentum Portfolio ETF'>PXI</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3267227\" data-linked=\"Energy stocks lead the way as Saudi-Russia oil agreement lifts crude 3%\" data-tweet=\"$NE $NE $DNR - Energy stocks lead the way as Saudi-Russia oil agreement lifts crude 3% https://seekingalpha.com/news/3267227-energy-stocks-lead-way-saudi-russia-oil-agreement-lifts-crude-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3267227-energy-stocks-lead-way-saudi-russia-oil-agreement-lifts-crude-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267226\" data-ts=\"1494850148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267226-ionis-pharmas-inotersen-successful-in-late-stage-fap-study-side-effects-pressure-shares-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ionis Pharma&#39;s inotersen successful in late-stage FAP study but side effects pressure shares, down 10% premarket</a></h4><ul><li>Ionis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a>) <a href=\"https://seekingalpha.com/pr/16832277-ionis-pharmaceuticals-announces-phase-3-neuro-ttr-study-inotersen-ionis-ttr-rx-meets-primary\" target=\"_blank\">announces </a>positive results from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT01737398?term=ionis+pharmaceuticals&amp;phase=2&amp;rank=2\" target=\"_blank\">NEURO-TTR</a>, assessing inotersen (IONIS-TTRrx) for the treatment of the inherited disorder familial amyloid polyneuropathy &#40;FAP&#41;. The study met both primary efficacy endpoints demonstrating a statistically valid treatment benefit compared to placebo.</li><li>Shares are down&nbsp;<font color='red'>10%</font>&nbsp;premarket on increased volume, however, as investors hit the sell buttons in response to the side effects of treatment. Three participants developed thrombocytopenia (low blood platelets), two recovered but one died from intracranial hemorrhage. Another patient discontinued treatment due to non-serious thrombocytopenia.</li><li>Four patients receiving inotersen stopped treatment due to kidney events; one from a renal observation, two from meeting a predefined renal stopping rule and one from chronic renal insufficiency (one patient in the control group also met the renal stopping rule).</li><li>The company says all five serious adverse events occurred before enhanced monitoring was fully implemented. A review of the safety data is ongoing.</li><li>Inotersen is an <a href=\"http://www.ionispharma.com/rd/antisense-technology/discovery-platform/\" target=\"_blank\">antisense</a> drug that targets a specific sequence of RNA. It is designed to reduce the production of a protein called transthyretin. It is administered once per week via injection.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267226\" data-linked=\"Ionis Pharma&#39;s inotersen successful in late-stage FAP study but side effects pressure shares, down 10% premarket\" data-tweet=\"$IONS - Ionis Pharma&#39;s inotersen successful in late-stage FAP study but side effects pressure shares, down 10% premarket https://seekingalpha.com/news/3267226-ionis-pharmas-inotersen-successful-in-late-stage-fap-study-side-effects-pressure-shares-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3267226-ionis-pharmas-inotersen-successful-in-late-stage-fap-study-side-effects-pressure-shares-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267220\" data-ts=\"1494849936\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BWLD\" target=\"_blank\">BWLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267220-deutshe-bank-sees-positive-changes-buffalo-wild-wings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutshe Bank sees positive changes at Buffalo Wild Wings</a></h4><ul> <li>Deutsche Bank takes Buffalo Wild Wings (<a href='https://seekingalpha.com/symbol/BWLD' title='Buffalo Wild Wings, Inc.'>BWLD</a>) to a Buy rating after having it set at Hold.</li> <li>The investment firm thinks that positive changes are in store for BWLD either through current management's initiatives or a \"strategic approach\" if the investment community goes in another direction.</li> <li>DB moves its price target on Buffalo Wild Wings up to <a href=\"https://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Upgrades+Buffalo+Wild+Wings%2C+Inc.+%28BWLD%29+to+Buy/12901061.html\" target=\"_blank\">$180.</a></li> <li>What to watch: Buffalo Wild Wing holds its annual meeting on June 2.</li> <li>BWLD <font color='green'>+0.86%</font> premarket to $158.70.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267220\" data-linked=\"Deutshe Bank sees positive changes at Buffalo Wild Wings\" data-tweet=\"$BWLD - Deutshe Bank sees positive changes at Buffalo Wild Wings https://seekingalpha.com/news/3267220-deutshe-bank-sees-positive-changes-buffalo-wild-wings?source=tweet\" data-url=\"https://seekingalpha.com/news/3267220-deutshe-bank-sees-positive-changes-buffalo-wild-wings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267209\" data-ts=\"1494849379\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WETF\" target=\"_blank\">WETF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267209-wisdomtree-up-2-after-citi-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WisdomTree up 2% after Citi upgrade</a></h4><ul><li>Risk/reward is \"tipped meaningfully to the upside,\" says analyst William Katz, upgrading WisdomTree (NASDAQ:<a href='https://seekingalpha.com/symbol/WETF' title='WisdomTree Investments, Inc.'>WETF</a>) to Buy from Neutral. He sees clear signs that fund flows and margins are set to turn higher.</li><li>As for another catalyst, Katz believes a sale of the company \"may be inevitable.\"</li><li>His new price target of $10.50 suggests nearly&nbsp;<font color='green'>17% upside</font>.</li><li>Source:<a href=\"https://thefly.com/permalinks/entry.php/id2552299/WETF-WisdomTree-rating-change-at-Citi\" target=\"_blank\"> TheFly</a></li><li>Shares&nbsp;<font color='green'>+2.1%</font>&nbsp;premarket to $9.21</li></ul><div class=\"tiny-share-widget\" data-id=\"3267209\" data-linked=\"WisdomTree up 2% after Citi upgrade\" data-tweet=\"$WETF - WisdomTree up 2% after Citi upgrade https://seekingalpha.com/news/3267209-wisdomtree-up-2-after-citi-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3267209-wisdomtree-up-2-after-citi-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267193\" data-ts=\"1494848114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267193-analysts-lose-confidence-in-j-c-penney\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts lose confidence in J.C. Penney</a></h4><ul> <li>Deutsche Bank loses faith in J.C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>)&nbsp;after observing the collapse of the DB&nbsp;thesis on outperformance by the department store chain against its peer group.</li> <li>The investment firm cuts its price target to $5.50.</li> <li>Baird lowers its rating to Neutral from Outperform and drops its price target to $5 from $8 after factoring in JCP's Q1 report.</li><li>Sources: Bloomberg and MarketBeat.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3266865-j-c-penney-slumps-sales-disappoint\" target=\"_blank\">J.C. Penney slumps after sales disappoint</a> (May 12)</li> <li>JCP <font color='red'>-1.10%</font> premarket to $4.50 vs. a 52-week trading range of $.48 (Friday) to $11.30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267193\" data-linked=\"Analysts lose confidence in J.C. Penney\" data-tweet=\"$JCP - Analysts lose confidence in J.C. Penney https://seekingalpha.com/news/3267193-analysts-lose-confidence-in-j-c-penney?source=tweet\" data-url=\"https://seekingalpha.com/news/3267193-analysts-lose-confidence-in-j-c-penney\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267190\" data-ts=\"1494847976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMO\" target=\"_blank\">TMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267190-pantheon-up-33-premarket-on-7_2b-thermo-fisher-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pantheon up 33% premarket on $7.2B Thermo Fisher bid</a></h4><ul><li>Thermo Fisher Scientific (NYSE:<a href='https://seekingalpha.com/symbol/TMO' title='Thermo Fisher Scientific Inc.'>TMO</a>) makes a <a href=\"https://seekingalpha.com/pr/16832334-thermo-fisher-scientific-acquire-patheon-leading-contract-development-manufacturing\" target=\"_blank\">$35/share tender offer</a> for all the outstanding stock of contract development and manufacturing organization Pantheon (NYSE:<a href='https://seekingalpha.com/symbol/PTHN' title='Patheon'>PTHN</a>), valuing the deal at ~$7.2B.</li><li>Fisher will fold the company, which generated ~$1.9B in revenues last year, into its Laboratory Products and Services Segment. The deal should add $0.30/share to non-GAAP EPS in the first 12 months after closing. It also expects to realize ~$120M in synergies by the third year. The transaction should close by year-end.</li><li>PTHN is up&nbsp;<font color='green'>33%</font>&nbsp;premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267190\" data-linked=\"Pantheon up 33% premarket on $7.2B Thermo Fisher bid\" data-tweet=\"$TMO $TMO $PTHN - Pantheon up 33% premarket on $7.2B Thermo Fisher bid https://seekingalpha.com/news/3267190-pantheon-up-33-premarket-on-7_2b-thermo-fisher-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3267190-pantheon-up-33-premarket-on-7_2b-thermo-fisher-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267184\" data-ts=\"1494847389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBUX\" target=\"_blank\">SBUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267184-deutsche-bank-constructive-on-starbucks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank constructive on Starbucks</a></h4><ul> <li>Deutsche Bank lifts Starbucks (NASDAQ:<a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a>) to a Buy rating after having the restautant stock set at Neutral.</li> <li>Analyst Brett Levy cites the recent strategic moves by the company, which he sees supporting the long-term growth story.</li> <li><a href=\"https://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Upgrades+Starbucks+%28SBUX%29+to+Buy%3B+Time+For+A+Refill%3F/12901067.html\" target=\"_blank\">DB note</a>: \"Time alone does not solve all issues (macro, traffic, labor challenges persist), but SBUX has been putting pieces in place to right its ship, in our opinion. Recent U.S. SSS improvements, refocused operations and the prospects for the coming years gives us reasons to be optimistic about the long-term story.\"</li><li>The new price target from Deutsche on Starbucks is $69.</li> <li>SBUX <font color='green'>+0.70%</font> premarket to $60.35.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3267184\" data-linked=\"Deutsche Bank constructive on Starbucks\" data-tweet=\"$SBUX - Deutsche Bank constructive on Starbucks https://seekingalpha.com/news/3267184-deutsche-bank-constructive-on-starbucks?source=tweet\" data-url=\"https://seekingalpha.com/news/3267184-deutsche-bank-constructive-on-starbucks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3267155\" data-ts=\"1494844868\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SORL\" target=\"_blank\">SORL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3267155-on-sorl-autos-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on SORL Auto&#39;s Q1</a></h4><ul><li>SORL Auto (NASDAQ:<a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a>) reports Domestic&nbsp;aftermarket sales rose 37.1% to $18.1M in <a href=\"https://seekingalpha.com/pr/16832214-sorl-auto-parts-reports-37_4-percent-increase-sales-significant-increase-eps-first-quarter\" target=\"_blank\">Q1</a>.</li><li>Domestic OEM customers sales expanded 48.8% to $41.8M due to higher truck sales.</li><li>International sales up 12% to $14M due to an organic expansion of the customer base across several overseas markets.</li><li>Total truck sales increased 30.9%, led by 93% growth in the heavy-duty segment.</li><li>Gross margin rate improved 100 bps to 27.8%.</li><li>Operating margin rate grew 1090 bps 13%.</li><li><b>FY2017 Guidance</b>: Net sales: ~$315M; Net income: ~$27.5M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3267155\" data-linked=\"More on SORL Auto&#39;s Q1\" data-tweet=\"$SORL - More on SORL Auto&#39;s Q1 https://seekingalpha.com/news/3267155-on-sorl-autos-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3267155-on-sorl-autos-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:41 AM </div></div></li>","count":70,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}